Merck Bolsters Animal Health Business in Peru with TARGAN Acquisition

Merck, a well-established pharmaceutical company, has expanded its presence in Peru's animal health market through the acquisition of TARGAN. The transaction marks Merck's continued commitment to growing its business in Latin America.

The terms of the deal were not disclosed, but it is evident that Merck sees potential for growth in Peru's animal health sector. With this acquisition, Merck aims to strengthen its position in the region and provide improved services to local farmers and veterinarians.